Recruiting Chronic Urticaria Studies in Indianapolis
Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)
This trial will be performed as a three-part dose escalating clinical trial where Parts 1 is open label and Parts 2 and 3 are randomized, double-blinded, and placebo-controlled. The trial is intended...
Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa
The study duration for an individual subject includes screening (14 days), the treatment period (28 days) and the observational follow-up period of 28 days, in total 70 days ± 6 days. All subjects wil...
About Chronic Urticaria Clinical Trials in Indianapolis
Chronic urticaria involves recurring episodes of itchy, red welts (hives) lasting more than six weeks. Chronic spontaneous urticaria (CSU) occurs without an identifiable trigger. Treatment includes antihistamines and biologics like omalizumab.
There are currently 2 chronic urticaria clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 155 participants. Research is being sponsored by Jasper Therapeutics, Inc., InflaRx GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Urticaria Clinical Trials in Indianapolis — FAQ
Are there chronic urticaria clinical trials in Indianapolis?
Yes, there are 2 chronic urticaria clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Indianapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.
Are clinical trials in Indianapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.
What chronic urticaria treatments are being tested?
The 2 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for chronic urticaria.
Data updated March 2, 2026 from ClinicalTrials.gov